Introduction
============

Following cardiac surgery, acute kidney injury (AKI) is an important complication in patients, occurring with a high incidence of 30%--40%.[@b1-tcrm-13-1499] The prognosis of AKI patients is quite poor both in the short term and in the long term, which puts a heavy burden on healthcare budgets.[@b2-tcrm-13-1499],[@b3-tcrm-13-1499] Preoperative renal dysfunction (RD) has been shown to be a high risk factor for cardiac surgery-associated AKI.[@b4-tcrm-13-1499],[@b5-tcrm-13-1499] Jyrala et al reported that in patients who received on-pump cardiac surgery, 20.6% had preoperative serum creatinine (SCr) levels ranging between 1.3 and 2.2 mg/dL. Furthermore, a modest increase in SCr levels added to the risk of postoperative AKI and to short-term mortality, even for long-term poor outcomes.[@b6-tcrm-13-1499] Aljadayel et al studied 340 patients who underwent cardiac valve surgery and found that 80 patients (30%) had preoperative mild RD, with the glomerular filtration rate estimated to be \<60 mL/min/1.73 m^2^, and this preoperative mild RD is an independent marker of postoperative morbidity (more red blood cell transfusions, reoperation, and longer hospital stay).[@b7-tcrm-13-1499] With age and increasing preoperative comorbidities including diabetes, hypertension, and peripheral angiopathy, the proportion of RD also increased, with the prevalence being ≥20%.[@b8-tcrm-13-1499] However, the pathophysiology of preoperative RD in patients who undergo cardiac surgery is quite unique. It is often caused by acute factors (cardiac shock/arrest, acute decompensated heart failure \[ADHF\], etc.) in a short period of time, but it may be reversible after the relief of these pathologies. Cardiac surgery is the only way to relieve hypoperfusion of the kidneys and maybe helpful in patients with reversible renal dysfunction (RRD). Thus, the judgment of the type of RD may be very important for surgical planning. But most studies on RD have mainly concentrated on chronic kidney disease (CKD), which is an irreversible condition,[@b9-tcrm-13-1499] and as far as we are aware, there are no studies about the relationship between improved cardiac function and renal outcomes. In the present study we compared changes in renal and cardiac functions of RD patients who underwent cardiac valve surgery, in order to evaluate the impact of the type of RD and changes in cardiac function on the risk of AKI and the short-term outcomes.

Patients and methods
====================

Patients
--------

The ethical committee of the Shanghai Zhongshan Hospital approved the study and written informed consent was obtained from all patients. Our study was performed in accordance with the Declaration of Helsinki regarding the ethical principles for medical research involving human subjects. The investigation was a retrospective, observational study in a cohort of patients who underwent cardiac surgery in Shanghai Zhongshan Hospital between April 2011 and February 2015. The study included adult patients with preoperative SCr \>1.2 (female)/1.5 (male) mg/dL.[@b10-tcrm-13-1499],[@b11-tcrm-13-1499] Exclusion criteria were being \<18 years old or had received renal replacement therapy (RRT) before surgery due to acute symptoms.

Definitions
-----------

AKI was defined using the Kidney Disease: Improving Global Outcomes (KDIGO) 2012 criteria[@b12-tcrm-13-1499] as the absolute value of the SCr increase ≥26.5 mmol/L within 48 h or an increase of \>50% compared to the baseline values within 7 d, or a urine output of \<0.5 mL/kg/h at ≥6 h.

CKD was diagnosed using the criteria defined in the KDIGO[@b13-tcrm-13-1499] as follows: 1) kidney damage for ≥3 months, either functional or structural abnormalities, with/without a decrease in glomerular filtration rate (GFR); 2) A GFR \<60 mL/min/1.73 m^2^ for ≥3 months, with/without damage to the kidneys. GFR was calculated using the chronic kidney disease epidemiology collaboration (CKD-EPI) equation: estimated GFR (eGFR) = a × (SCr/b)^c^ × (0.993)^age^ where a =144 (females)/141 (males); b =0.7 (females)/0.9 (males); c = female: −0.329 (SCr ≤0.7 mg/dL)/−1.209 (SCr \>0.7 mg/dL), male: −0.411 (SCr ≤0.7 mg/dL)/−1.209 (SCr \>0.7 mg/dL).

RRD was defined when patients had a preoperative SCr \>1.2 (female)/1.5 (male) mg/dL but had not been diagnosed with CKD, probably caused by I or II cardio-renal syndrome (CRS), or other acute causes.

ΔLVEF (left ventricular ejection function) = postoperative LVEF − preoperative LVEF; cardiac function not significantly improved: (CFNI) = ΔEF ≤0%; cardiac function improved (CFI) = ΔEF \>0%.

Preoperative LVEF was measured routinely at hospital admission. Postoperative LVEF was recorded before patient discharge, after the patient had been transferred from ICU to a ward. No cardiotonic agents were used at that time as they may have impacted the results. SCr at discharge was recorded as the last measurement before discharge, to prevent hemodilution due to fluid resuscitation after surgery.

Groups
------

All patients who underwent cardiac surgery were grouped as follows: the preoperative normal renal function (normal) group (n=4,504) and the preoperative RD group (n=301). Depending on postoperative cardiac functional changes, the RD patients were arranged into the CFI group (n=174) and the CFNI group (n=127). They were further divided into four subgroups: CKD and the CFI group, CKD and the CFNI group, RRD and the CFI group, RRD and CFNI group, respectively ([Figure 1](#f1-tcrm-13-1499){ref-type="fig"}). The AKI, AKI--RRT incidence, and in-hospital mortality were the primary endpoints.

Statistical analysis
--------------------

All data were analyzed with SPSS for Windows (Ver. 16.0., SPSS Inc., Chicago, IL, USA). Normally distributed data are presented as the mean ± SD; comparisons between groups were made using the two independent sample *t*-tests. Nonparametric data are presented as medians (25%--75% interquartile ranges). The Wilcoxon test was used to compare two dependent variables, a nonparametric Mann--Whitney test for comparing independent variables, and a chi-squared test for comparing between groups. Logistic regression analysis was used to investigate the influence of multiple factors on the incidence of AKI. A *P*-value \<0.05 was considered to be statistically significant.

Results
=======

Characteristic features of patients
-----------------------------------

A total of 4,805 patients underwent cardiac valve surgery from April 2011 to February 2015, including 4,504 (94%) in the normal group and 301 (6%) in the RD group. Of the 301 RD patients, there were 252 (84%) in the RRD group and 49 (16%) in the CKD group.

Patients in the RRD and CKD groups were older than in the normal group, with significantly more male patients. Comorbidities including hypertension and diabetes were significantly greater in the RRD and CKD groups than in the normal group. Preoperative SCr and SCr levels at discharge in the RRD group were significantly lower than in the CKD group (1.4±0.4 vs 1.8±0.7 mg/dL, *P*\<0.01; 1.5±0.9 vs 1.9±1.0 mg/dL, *P*\<0.01). The length of stay in hospital in the CKD group was significantly longer than in the RRD and normal groups (20±14 vs 16±8 d, *P*\<0.01; 20±14 vs 13±8 d, *P*\<0.01) ([Table 1](#t1-tcrm-13-1499){ref-type="table"}).

AKI incidence in different postoperative cardiac function groups
----------------------------------------------------------------

Of the 301 RD patients, 174 (58%) were in the CFI group and 127 (42%) were in the CFNI group. The AKI and AKI--RRT incidence in the CFI group were significantly lower than in the CFNI group (33.9% vs 50.4%, *P*=0.004; 6.3% vs 13.4%, *P*=0.037) ([Table 2](#t2-tcrm-13-1499){ref-type="table"}).

Outcomes in the subgroups
-------------------------

The incidence of AKI in the RRD group was significantly lower than in the CKD group (36.5% vs 63.3%, *P*=0.018). The AKI and RRT incidence and in-hospital mortality in the RRD group were significantly greater than in the normal group (36.5% vs 28.4%, *P*=0.006; 8.3% vs 2.0%, *P*\<0.001; 6.0% vs 2.6%, *P*=0.002). Subgroup analysis showed that there were no significant differences of AKI incidence and in-hospital mortality in the RRD + CFI group and the normal group (30.3 vs 28.4%, *P*=0.624; 4.2% vs 2.6%, *P*=0.234). The RRT incidence in the RRD + CFI group was significantly higher than in the normal group. The AKI and RRT incidence and in-hospital mortality in the RRD + CFNI group were greater than in the normal group ([Table 3](#t3-tcrm-13-1499){ref-type="table"}, [Figure 2](#f2-tcrm-13-1499){ref-type="fig"}). The incidence of AKI and RRT and in-hospital mortality in the CKD group were greater than in the normal group (63.3% vs 28.4, *P*\<0.001; 14.3% vs 2.0%, *P*\<0.001; 10.2% vs 2.6%, *P*=0.001). Subgroup analysis showed that the incidence of AKI and RRT and in-hospital mortality in the CKD + CFI and CKD + CFNI groups were greater than in the normal group ([Figure 2](#f2-tcrm-13-1499){ref-type="fig"} and [Table 3](#t3-tcrm-13-1499){ref-type="table"}).

Use of logistic regression analysis to assess the risk factors for developing postoperative AKI
-----------------------------------------------------------------------------------------------

The use of multivariate logistic regression analysis revealed the independent risk factors for AKI in patients who underwent cardiac valve surgery were: age, gender (male), body mass index (BMI), hypertension, chronic heart failure (CHF), cardiopulmonary bypass (CPB) time (every 1 min added), and intraoperative hypotension ([Table 4](#t4-tcrm-13-1499){ref-type="table"}). After adjustments for age, gender, and other confounding factors, postoperative AKI and CKD were independent risk factors, with RRD not significantly adding to the risk. Further analysis showed that CKD + CFNI was a highly significant independent risk factor for AKI ([Table 5](#t5-tcrm-13-1499){ref-type="table"}).

Independent risk factors for AKI in preoperative RD patients were age, gender (male), hypertension, diabetes, CHF, CPB time (every 1 min added), and intraoperative hypotension, while improved cardiac function after surgery can reduce the risk ([Table 6](#t6-tcrm-13-1499){ref-type="table"}).

Discussion
==========

Our results have shown that of the 301 RD patients who underwent valve surgery, 84% were diagnosed with RRD while only 16% with CKD. RD can be acute (AKI) or chronic (CKD). The causes of AKI can be broadly divided into three pathophysiological categories namely prerenal, intrarenal or intrinsic, and postrenal.[@b14-tcrm-13-1499] Prerenal AKI is usually caused by renal hypoperfusion due to sepsis or heart failure, and is often readily reversible. Intrarenal AKI is usually caused by progression of prerenal azotemia and worsening ischemia, which are not easy to reverse. Postrenal AKI is often found in patients presenting with prostatic hypertrophy or retroperitoneal disorders. Patients undergoing cardiac valve surgery often have a reduced cardiac output (CO) and decreased effective intravascular volume, which lead to renal hypoperfusion and ischemia. Thus, the major type of RD may be prerenal AKI with most patients not having progressed into CKD.

Our results also revealed that the incidence of AKI in the RRD group was significantly less than in the CKD group. Furthermore, both in the RRD and the CKD groups, the incidence of AKI was significantly higher compared with the normal group ([Table 2](#t2-tcrm-13-1499){ref-type="table"}). Over the years, though the definition has varied, preoperative RD is always an independent high risk factor for AKI and poor outcomes.[@b4-tcrm-13-1499],[@b5-tcrm-13-1499] Mehta et al confirmed that the risk of AKI increased with increasing preoperative SCr levels.[@b4-tcrm-13-1499] Volkmann et al found that a preoperative SCr level \>1.5 mg/dL doubled the risk of death and also produced a longer hospital stay.[@b15-tcrm-13-1499] Our previous study also showed that a preoperative SCr level \>106 μmol/L is an important independent risk factor for postoperative AKI.[@b16-tcrm-13-1499]

In recent years, much attention has been paid to CRS, which is common in patients undergoing cardiac surgery.[@b17-tcrm-13-1499]--[@b19-tcrm-13-1499] CRS type 2 is caused by chronic heart failure (CHF) leading to kidney injury or dysfunction,[@b18-tcrm-13-1499] with CKD being diagnosed in 26%--63% of CHF patients.[@b20-tcrm-13-1499] Nguyen et al found that preexisting RD (eGFR \<60 mL/min/1.73 m^2^) occurred in 32% of aortic valve replacement patients, and that RD was associated with the period of time spent in hospital, the duration in the ICU, and increased in-hospital mortality.[@b21-tcrm-13-1499] RD can also be triggered by rapidly worsening cardiac function, which is termed as CRS type 1, and it mostly occurs in patients with ADHF.[@b22-tcrm-13-1499],[@b23-tcrm-13-1499] In our study of 4,805 patients who underwent cardiac valve surgery, only 6% had a preoperative SCr level \>1.2 mg/dL, much lower values than reported in the above studies. Thus, it can be inferred that most RD patients were not be considered for surgery in our hospital, even though the majority of them may not be susceptible to AKI.

The most important observation in the present study was that preoperative RRD did not add to the risk of postoperative AKI; only CKD did. For CKD patients, the kidney often has fibrosis and necrosis of the glomerulus, which are irreversible by surgery. Therefore, the management of perioperative modifiable factors such as anemia, diabetes, contrast-media insult, and fluid resuscitation should be enhanced if surgery is necessary. In RRD patients, prerenal injury in its early stages can often be rapidly corrected by returning the effective arterial volume to normal to facilitate early surgical intervention. A number of studies have also reported that impaired renal function can be improved by cardiac resynchronization[@b24-tcrm-13-1499] or left ventricular assist devices.[@b25-tcrm-13-1499] The type of RD should be judged according to a patient's history, symptoms, laboratory examinations, and other investigations such as renal ultrasound and so on, and even family history. Mild elevated SCr levels or decreased eGFR does not mean mild injury of the kidney; also high level of SCr does not necessarily equate to CKD. The diagnosis is often difficult because of a lack of basic renal function in most patients so that experienced nephrologists are necessarily required.

Another important finding of our study was that improved postoperative cardiac function can significantly reduce the risk of postoperative AKI. Valve disorder is often caused by rheumatism or congenital disease. The progression is very slow, even over decades, so that the majority of patients have progressive heart failure. Our results also showed a high proportion of CHF ([Table 1](#t1-tcrm-13-1499){ref-type="table"}), but that 58% of patients had improved cardiac function after surgery. On the one hand, cardiac surgery is an important cause of postoperative AKI, while on the other hand, surgery of this type is the only choice for patients with severe heart disease, which can improve cardiac function and relieve hypoperfusion of the kidneys.

Our study has some limitations. It was a single-center retrospective study that lacked follow-up of long-term outcomes of cardiac and renal functions. The incomplete data about basic renal functions in some patients may lead to bias for the diagnosis of the type of RD, and further studies are necessary.

Conclusions
===========

It is important to remember that the risk of preoperative RD patients undergoing cardiac valve surgery depends on the type of RD. Preoperative CKD is an independent risk factor for postoperative AKI, suggesting that the indication for surgery should be made with more caution. RRD did not add to the risk, so the surgery should be carried out as soon as possible.
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###### 

Basic characteristics of patients who underwent cardiac valve surgery

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristics                        RRD group\                                                                                            CKD group\                                              Normal group\
                                         n=252                                                                                                 n=49                                                    n=4,504
  -------------------------------------- ----------------------------------------------------------------------------------------------------- ------------------------------------------------------- ---------------
  Age                                    58±13[a](#tfn1-tcrm-13-1499){ref-type="table-fn"}                                                     62±11[b](#tfn2-tcrm-13-1499){ref-type="table-fn"}       51±12

  Male (n, %)                            190 (75.4)[a](#tfn1-tcrm-13-1499){ref-type="table-fn"}                                                40 (81.6)[b](#tfn2-tcrm-13-1499){ref-type="table-fn"}   2,020 (44.8)

  BMI (kg/m^2^)                          22±3                                                                                                  23±3                                                    23±3

  Hypertension (n, %)                    89 (35.3)[a](#tfn1-tcrm-13-1499){ref-type="table-fn"}                                                 23 (46.9)[b](#tfn2-tcrm-13-1499){ref-type="table-fn"}   950 (21.1)

  Diabetes (n, %)                        28 (11)[a](#tfn1-tcrm-13-1499){ref-type="table-fn"}                                                   7 (14)[b](#tfn2-tcrm-13-1499){ref-type="table-fn"}      233 (5)

  CHF (n, %)                             185 (73.4)                                                                                            37 (75.5)                                               3,058 (67.9)

  Coronary angiography (n, %)            109 (43.3)[a](#tfn1-tcrm-13-1499){ref-type="table-fn"},[c](#tfn3-tcrm-13-1499){ref-type="table-fn"}   36 (73.5)                                               1,391 (30.9)

  Preoperative LVEF (%)                  57±11[a](#tfn1-tcrm-13-1499){ref-type="table-fn"}                                                     57±12[b](#tfn2-tcrm-13-1499){ref-type="table-fn"}       63±9

  Preoperative SCr (mg/dL)               1.4±0.4[a](#tfn1-tcrm-13-1499){ref-type="table-fn"},[c](#tfn3-tcrm-13-1499){ref-type="table-fn"}      1.8±0.7[b](#tfn2-tcrm-13-1499){ref-type="table-fn"}     0.8±0.2

  Preoperative eGFR (mL/min/1.73 m^2^)   58±23[a](#tfn1-tcrm-13-1499){ref-type="table-fn"},[c](#tfn3-tcrm-13-1499){ref-type="table-fn"}        45±14[b](#tfn2-tcrm-13-1499){ref-type="table-fn"}       95±21

  Proteinuria (n, %)                     23 (9)[c](#tfn3-tcrm-13-1499){ref-type="table-fn"}                                                    29 (59)[b](#tfn2-tcrm-13-1499){ref-type="table-fn"}     311 (7)

  CPB duration (min)                     103±38[a](#tfn1-tcrm-13-1499){ref-type="table-fn"},[c](#tfn3-tcrm-13-1499){ref-type="table-fn"}       83±25                                                   91±34

  Aortic clamping duration (min)         62±26[a](#tfn1-tcrm-13-1499){ref-type="table-fn"},[c](#tfn3-tcrm-13-1499){ref-type="table-fn"}        45±17                                                   56±24

  Intraoperative hypotension (n, %)      54 (21)[a](#tfn1-tcrm-13-1499){ref-type="table-fn"}                                                   12 (24)[b](#tfn2-tcrm-13-1499){ref-type="table-fn"}     238 (5)

  ICU stay (h)                           55 (23, 95)[a](#tfn1-tcrm-13-1499){ref-type="table-fn"}                                               46 (20, 119)                                            25 (20, 65)

  Length of hospital stay (d)            16±8[a](#tfn1-tcrm-13-1499){ref-type="table-fn"},[c](#tfn3-tcrm-13-1499){ref-type="table-fn"}         20±14[b](#tfn2-tcrm-13-1499){ref-type="table-fn"}       13±8

  SCr at discharge (mg/dL)               1.5±0.9[a](#tfn1-tcrm-13-1499){ref-type="table-fn"},[c](#tfn3-tcrm-13-1499){ref-type="table-fn"}      1.9±1.0[b](#tfn2-tcrm-13-1499){ref-type="table-fn"}     0.9±0.4
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:**

*P*\<0.05 RRD vs normal group;

*P*\<0.05 CKD vs normal group;

*P*\<0.05 RRD vs CKD group.

**Abbreviations:** BMI, body mass index; CHF, chronic heart failure; CKD, chronic kidney disease; CPB, cardiopulmonary bypass; eGFR, estimated glomerular filtration rate; ICU, intensive care unit; LVEF, left ventricular ejection function; RRD, reversible renal dysfunction; SCr, serum creatinine

###### 

AKI incidence in different postoperative cardiac function groups

  Groups   n     AKI incidence (%)                                       RRT incidence (%)                           
  -------- ----- ------------------------------------------------------- ------------------- ----------- ----------- ------------------------------------------------------
  CFI      174   59 (33.9)[a](#tfn5-tcrm-13-1499){ref-type="table-fn"}   28 (16.1)           15 (8.6)    16 (9.2)    11 (6.3)[a](#tfn5-tcrm-13-1499){ref-type="table-fn"}
  CFNI     127   64 (50.4)                                               26 (20.5)           20 (15.7)   18 (14.2)   17 (13.4)

**Notes:**

*P*\<0.05 compared with CFNI group. AKI 1,2 and 3 represent AKI stage 1,2 and 3.

**Abbreviations:** AKI, acute kidney injury; CFI, cardiac function improved; CFNI, cardiac function not improved; RRT, renal replacement therapy.

###### 

Outcomes in subgroups

  Groups         n       AKI incidence (%)                                                                                    AKI 1 (%)    AKI 2 (%)   AKI 3 (%)   RRT incidence (%)                                       In-hospital mortality (%)
  -------------- ------- ---------------------------------------------------------------------------------------------------- ------------ ----------- ----------- ------------------------------------------------------- ------------------------------------------------------
  Normal group   4,504   1,279 (28.4)                                                                                         775 (17.2)   324 (7.2)   180 (4.3)   90 (2.0)                                                117 (2.6)
  RRD group      252     92 (36.5)[a](#tfn7-tcrm-13-1499){ref-type="table-fn"},[b](#tfn8-tcrm-13-1499){ref-type="table-fn"}   41 (16.3)    29 (11.4)   22 (8.8)    21 (8.3)[a](#tfn7-tcrm-13-1499){ref-type="table-fn"}    15 (6.0)[a](#tfn7-tcrm-13-1499){ref-type="table-fn"}
  RRD + CFI      142     43 (30.3)                                                                                            25 (17.6)    10 (7.0)    8 (5.6)     7 (4.9)[a](#tfn7-tcrm-13-1499){ref-type="table-fn"}     6 (4.2)
  RRD + CFNI     110     49 (44.5)[a](#tfn7-tcrm-13-1499){ref-type="table-fn"}                                                20 (18.2)    16 (14.5)   13 (11.8)   14 (12.7)[a](#tfn7-tcrm-13-1499){ref-type="table-fn"}   9 (8.2)[a](#tfn7-tcrm-13-1499){ref-type="table-fn"}
  CKD group      49      31 (63.3)[a](#tfn7-tcrm-13-1499){ref-type="table-fn"}                                                11 (22.4)    9 (18.4)    11 (22.4)   7 (14.3)[a](#tfn7-tcrm-13-1499){ref-type="table-fn"}    5 (10.2)[a](#tfn7-tcrm-13-1499){ref-type="table-fn"}
  CKD + CFI      32      16 (50.0)[a](#tfn7-tcrm-13-1499){ref-type="table-fn"}                                                3 (9.4)      5 (15.6)    8 (25.0)    4 (12.5)[a](#tfn7-tcrm-13-1499){ref-type="table-fn"}    3 (9.4)[a](#tfn7-tcrm-13-1499){ref-type="table-fn"}
  CKD + CFNI     17      15 (88.2)[a](#tfn7-tcrm-13-1499){ref-type="table-fn"}                                                6 (35.3)     4 (23.5)    5 (29.4)    3 (17.6)[a](#tfn7-tcrm-13-1499){ref-type="table-fn"}    2 (11.8)[a](#tfn7-tcrm-13-1499){ref-type="table-fn"}

**Notes:**

*P*\<0.05 compared with the normal group;

*P*\<0.05 compared with the CKD group. AKI 1,2 and 3 represent AKI stage 1,2 and 3.

**Abbreviations:** AKI, acute kidney injury; CFI, cardiac function improved; CFNI, cardiac function not improved; CKD, chronic kidney disease; RRD, reversible renal dysfunction; RRT, renal replacement therapy.

###### 

Multivariate logistic regression analysis of risk factors for postoperative AKI in all patients after cardiac valve surgery

  Characteristics                    OR     95% CI          *P*-value
  ---------------------------------- ------ --------------- -----------
  Age                                1.07   1.060--1.081    \<0.01
  Gender (male)                      1.45   1.188--1.773    \<0.01
  BMI                                1.05   1.012--1.078    0.007
  Hypertension                       1.81   1.450--2.258    \<0.01
  CHF                                1.47   1.185--1.826    \<0.01
  Preoperative RD                    1.59   1.088--2.310    0.016
  CPB duration (every 1 min added)   1.01   1.010--1.016    \<0.01
  Intraoperative hypotension         6.45   1.328--20.756   \<0.01

**Abbreviations:** AKI, acute kidney injury; BMI, body mass index; CHF, chronic heart failure; CPB, cardiopulmonary bypass; OR, odds ratio; RD, renal dysfunction.

###### 

Analysis of outcome risk factors for postoperative AKI after adjusted for age, gender, and other factors

  Groups                              OR      95% CI              *P*-value
  ----------------------------------- ------- ------------------- -----------
  Normal renal function (reference)   --      1.000 (reference)   --
  RRD                                 1.25    0.822--1.913        0.293
  CKD                                 4.38    1.855--10.341       \<0.01
  RRD + CFI                           1.54    0.783--3.029        0.211
  RRD + CFNI                          1.44    0.686--3.019        0.336
  CKD + CFI                           2.98    0.942--9.457        0.063
  CKD + CFNI                          16.50   1.806--50.823       0.011

**Note:** "--" indicates no value.

**Abbreviations:** AKI, acute kidney injury; CFI, cardiac function improved; CFNI, cardiac function not improved; CKD, chronic kidney disease; OR, odds ratio; RRD, reversible renal dysfunction.

###### 

Multivariate logistic regression analysis of risk factors for postoperative AKI in RD patients after cardiac valve surgery

  Characteristics                    OR      95% CI          *P*-value
  ---------------------------------- ------- --------------- -----------
  Age                                1.05    1.003--1.093    0.038
  Gender (male)                      1.28    1.090--2.924    0.036
  Hypertension                       1.92    1.350--2.418    0.006
  Diabetes                           3.54    1.499--25.094   0.026
  CHF                                1.42    1.046--4.313    0.039
  CPB duration (every 1 min added)   2.01    1.007--2.982    \<0.01
  Intraoperative hypotension         7.02    2.019--24.391   0.002
  Improvement of cardiac function    0.097   0.010--0.934    0.041

**Abbreviations:** AKI, acute kidney injury; CHF, chronic heart failure; CPB, cardiopulmonary bypass; OR, odds ratio; RD, renal dysfunction.
